Webinar
Upcoming Webinar
In collaboration with

Beyond Diagnosis: Standardizing Fragmented Clinical Data with OMOP and LLMs

What the AI Co-Scientist Paper Actually Demonstrates for Biologists and Data Scientists

April 7, 2026
9 AM PT

Two patients with the same diagnosis often show very different disease trajectories and treatment responses. For clinical and research teams, the goal is clear: identify meaningful patient subgroups that go beyond traditional labels.
One approach to this problem is to combine real-world clinical data (EHR) with molecular datasets (like TCGA) and apply unsupervised learning to uncover hidden patterns. But this is where most efforts break down.
EHR data is fragmented across systems, inconsistent in coding (ICD, SNOMED, proprietary formats), and often buried in free text. At the same time, public datasets like TCGA are structured but lack the clinical context needed for real-world applications. Without a common representation, it becomes difficult to generate reliable patient features, making downstream clustering and stratification noisy and hard to reproduce.
In this session, we walk through how this can be addressed in practice.

We’ll show how standardizing clinical data using the OMOP Common Data Model, combined with LLM-assisted workflows, can transform fragmented datasets into consistent, analysis-ready patient cohorts. Using real examples, we’ll demonstrate how heterogeneous clinical tables can be converted into model-ready datasets that support meaningful patient clustering and discovery.

Register Now
Please enter only business email id.
Thank you for registering.

Please check your inbox for further details to join this webinar.
Oops! Something went wrong while submitting the form.
Registrations are closed!
Meet the Expert of this discussion
Manimala Sen
Director - Technical Product
Pawan Verma
Lead - Bioinformatics Engineer, Elucidata

Real-World Applications We’ll Cover

  • Scaling clinico-genomic data integration: Large pharmaceutical organizations working with external data providers used Polly to build interoperable clinico-genomic data products 6x faster.
    Although purchased datasets are often labeled as "clean," they still lack interoperability—Polly's pipelines bridge this gap with robust integration and harmonization.

  • Information Retrieval: Drug safety monitoring teams used Polly's Knowledge Graph powered co-scientist to conversationally retrieve the right cohorts & assess drug response—cutting discovery time by 70%.

Register now
Join us for a behind-the-scenes look at a Multi-agent AI system that achieves:
  • 93% recall across 23 key metadata fields including tissue, disease, cell line, donor ID, and treatment.
  • Outperformance of GPT-4.1 single-pass prompting on accuracy, F1 score, and traceability.
  • Curation of 4652 samples from 78 GEO datasets in days instead of weeks.
  • 4x reduction in manual effort equivalent to replacing a 3-person expert team working for 1 month.
  • Human-level accuracy, with 100% concordance on disease and 97% on gender based on CellxGene benchmarks.
  • Traceable records with field-level evidence attribution and confidence scores.
Register for our webinar to see how the Agentic AI system fits into scalable data workflows.

What You’ll Learn

  • Understand why fragmented, inconsistent EHR data limits patient stratification
  • How the OMOP Common Data Model harmonises structure for ehr data.
  • LLM-assisted OMOP mapping can help convert unstructured, heterogeneous clinical data and diverse tables into a unified OMOP-based, model-ready dataset for reliable analysis.
  • Approaches to enable meaningful patient clustering and subgroup discovery
  • Real-world examples of converting raw unstructured clinical data into actionable insights
Register now
Meet the Expert of this discussion
Manimala Sen
Director - Technical Product
Pawan Verma
Lead - Bioinformatics Engineer, Elucidata
Meet the Expert of this discussion
Manimala Sen
Director - Technical Product
Pawan Verma
Lead - Bioinformatics Engineer, Elucidata
What Sets polly KG Apart
Natural language querying with reasoning on
the roadmap
Cross-species graphs built from both proprietary
and public data
Custom scoring logic and domain-specific
ontology support
Seamless integration with internal tools, platforms,
and security frameworks
Who Should Attend
Translational Scientists and Discovery Leads
Computational Biologists and Data Scientists
Platform Owners, heads of R&D IT
Innovation and AI Strategy Teams
Who Should Attend
Translational Scientists and Discovery Leads
Data Science & Informatics Teams
Computational Biologists and R&D IT Leaders
Innovation & AI Strategy Teams

Why This Matters for Biomedical Researchers

Adopting a Data-Centric and OOD-aware approach is essential for delivering real therapeutic impact.

If you’re working with complex biological data, you may be asking:

  • Can generative AI truly assist in scientific reasoning, not just data analysis?

  • What does it mean for hypothesis generation, literature review, or even designing experiments?

  • Could this accelerate—not replace—my discovery pipeline?

Whether you're skeptical, curious, or already experimenting with AI in your lab—this is a session designed to ground your understanding in evidence, not speculation.

  • Standardise Clinical Data: Eliminates fragmentation and inconsistency in EHR data, enabling robust, scalable analysis and improving the quality of insights.
  • Reliable Patient Stratification: Drives more precise patient subgrouping, leading to better-targeted research and more effective clinical decision-making.
  • Improved Reproducibility: Standardization with OMOP ensures analyses can be consistently replicated across datasets and studies
  • Faster Pipeline: Reduces time spent on manual data cleaning and structuring.
  • Build Reproducible Cohorts: Get practical tips for creating analysis-ready patient cohorts.

Traditional KG

  • Standardise Clinical Data: Eliminates fragmentation and inconsistency in EHR data, enabling robust, scalable analysis and improving the quality of insights.
  • Reliable Patient Stratification: Drives more precise patient subgrouping, leading to better-targeted research and more effective clinical decision-making.
  • Improved Reproducibility: Standardization with OMOP ensures analyses can be consistently replicated across datasets and studies
  • Faster Pipeline: Reduces time spent on manual data cleaning and structuring.
  • Build Reproducible Cohorts: Get practical tips for creating analysis-ready patient cohorts.

Polly KG

Register now
Meet the Experts of this discussion
Manimala Sen
Director - Technical Product
Pawan Verma
Lead - Bioinformatics Engineer, Elucidata
Harshveer Singh
Director Engineering Research & Development, Elucidata
Key Takeaways
How data providers ensure adherence to quality standards through validation and compliance.
How GUI-based workflows, CLI tools, and collaborative workspaces enable streamlined data ingestion and synchronization at scale.
Understand how automated pipelines assess conformance, plausibility, and consistency, ensuring high-quality, AI-ready data products.
Key Takeaways
Reduce operational costs by streamlining data delivery through reusable, governed products.
Accelerate diagnostic development and clinical trial execution by delivering compliant, high-quality data at scale.
Improve audit readiness and regulatory confidence through governed data products and built-in quality assurance.
Equip cross-functional teams to act on trusted data—faster, and with greater confidence.
Who Should Attend
Translational Scientists and Discovery Leads
Computational Biologists and Data Scientists
Platform Owners, heads of R&D IT
Innovation and AI Strategy Teams
What Sets polly KG Apart
First KG to integrate molecular data alongside patient data records
Feature distillation pipeline for high-dimensional clinical and trial data
Base KG usable immediately, with flexible schema extensions
Cross-species graphs built from proprietary, public, and clinical datasets
Who Should Attend?

All Webinars